Canine Heart Disease Guide: ARVC vs. MMVD

Beyond the Murmur: A Deep Dive into Two Common Canine Heart Diseases

Heart disease is a leading health concern for dogs, but it’s not a single entity. Veterinary cardiology reveals distinct diseases with unique mechanisms. Two of the most significant are Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and Myxomatous Mitral Valve Disease (MMVD). Recent research, including pivotal reviews in the Journal of Veterinary Cardiology, provides a clearer picture of their causes, progression, and management, empowering owners to partner with their veterinarians for proactive care.

Decoding the Electrical Storm: Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

As detailed in a 2022 review, ARVC is a serious inherited disease primarily affecting Boxers and English Bulldogs. At its core, it is a disorder of the desmosome—the microscopic “glue” that holds heart muscle cells together. When these desmosomal proteins are faulty due to a genetic mutation, the connections fail. Over time, the stressed heart muscle cells die and are replaced by fatty or fibrous scar tissue, particularly in the right ventricle.

This structural decay sets the stage for the disease’s hallmark: dangerous ventricular arrhythmias. The scar tissue disrupts the heart’s electrical signaling, causing it to beat chaotically. An affected dog may appear normal until a sudden episode of fainting (syncope) or, tragically, sudden cardiac death, often during excitement or exercise. In some cases, the disease progresses to involve the left ventricle, leading to congestive heart failure characterized by fluid buildup in the lungs or abdomen. The parallels between canine and human ARVC are striking, making affected dogs an important model for advancing medicine across species.

The Mechanics of a Leaky Valve: Myxomatous Mitral Valve Disease (MMVD)

In stark contrast to ARVC’s electrical and muscular origin, MMVD—the most common heart disease in dogs—is a structural failure of a specific component. As explained in a foundational 2012 pathology review, the mitral valve is a complex apparatus that ensures blood flows one-way from the left atrium to the left ventricle. In MMVD, the valve undergoes a degenerative “myxomatous” change.

The robust, collagen-rich layer of the valve leaflet (the fibrosa) weakens and thins. Simultaneously, the middle layer (the spongiosa) becomes engorged with glycosaminoglycans—spongy, jelly-like substances. This causes the valve to become thick, nodular, and floppy. It no longer seals properly, allowing blood to leak backward (regurgitate) with each heartbeat. This leak creates a murmur your veterinarian can hear. The chronic volume overload from this leak stretches the heart chambers, potentially leading to congestive heart failure, and in severe cases, can cause chordae tendineae (the heart’s “guy-wires”) to rupture. Nearly all older, small-breed dogs develop some degree of MMVD, highlighting a species-specific vulnerability.

From Research to Reality: What This Means for Your Dog’s Heart Health

Understanding these distinct mechanisms transforms how we view prevention, diagnosis, and care. It underscores that “heart disease” is not one-size-fits-all.

• Breed Matters: ARVC has a strong genetic component in specific breeds. Responsible breeders screen breeding stock with 24-hour Holter monitors to quantify arrhythmias. For MMVD, while common in all dogs, Cavalier King Charles Spaniels have a severe, early-onset form, indicating a strong heritable link.
• Diagnosis is Multifaceted: A murmur points to MMVD, but an echocardiogram (heart ultrasound) is needed to assess its severity. For ARVC in a Boxer with fainting spells, a normal echocardiogram doesn’t rule it out; a Holter monitor to catch erratic heart rhythms is essential.
• Treatment Targets the Problem: ARVC therapy focuses on anti-arrhythmic drugs (like Sotalol) to suppress life-threatening irregular beats. MMVD treatment, initiated at the onset of heart failure, centers on drugs like Pimobendan to improve cardiac efficiency and diuretics to manage fluid buildup. A proactive weight management and exercise plan is crucial for both conditions to reduce cardiac workload.

Practical Takeaways for Proactive Canine Cardiac Care

While genetics play a role, an evidence-based lifestyle can support overall cardiovascular resilience.

• Know Your Dog’s Risk: Research your breed’s predispositions. Schedule regular veterinary exams where your vet listens carefully to the heart. A new murmur or change in a known murmur is a significant event.
• Embrace Targeted Nutrition: For dogs with established heart disease, veterinary-prescribed cardiac diets are formulated with optimal levels of sodium, protein, and heart-supportive nutrients like taurine and L-carnitine. The omega-3 fatty acids EPA and DHA, found in fish oil for dogs, have strong evidence for reducing inflammatory cytokines and potentially helping to manage muscle loss in advanced heart failure.
• Monitor at Home: Learn to take your dog’s resting respiratory rate at home. A consistent increase can be the first sign of pulmonary edema from heart failure and warrants an immediate vet visit.
• Support Overall Cellular Health: Emerging research into aging dogs explores compounds like rapamycin for supporting cellular repair processes. While not a heart disease treatment, studies like the TRIAD trial investigate its potential to improve overall healthspan, which includes cardiovascular function. Always consult your veterinarian before introducing any supplement.

The landscape of canine cardiology is moving from generic management to precise, mechanism-based care. By distinguishing between the electrical dysfunction of ARVC and the valve degeneration of MMVD, owners and veterinarians can work together earlier and more effectively, aiming not just for longer life, but for better heart health throughout a dog’s journey. A foundation of excellent canine nutrition and preventive care from the puppy vaccination stage onward sets the stage for lifelong wellness.

Sources:
https://pubmed.ncbi.nlm.nih.gov/34503916/
https://pubmed.ncbi.nlm.nih.gov/22386587/
https://pubmed.ncbi.nlm.nih.gov/27286907/